In addition, and as further evidence that these malignant cells were switch T cells, the switching defect in a patient with immunodeficiency and hyper-IgM was corrected in vitro.
Materials and Methods
Patient Material. Heparinized blood was obtained from patient Rac, a patient with a mycosis fungoides/Sezary-like syndrome characterized by the presence of papular skin lesions with Sezary cells noted on biopsy. There were no classical Pautrier's abscesses present. The patient's serum Ig profile consisted of an IgG of 2,480 mg%, an IgA of 1,140 rag%, and no detectable IgM, as determined by standard radial immunodiffusion technique (18) . A bone marrow aspirate revealed 13% plasma cells. Of these, ~50% contained IgG and 50% contained IgA. Very few IgM plasma cells were found. Peripheral blood smears revealed 10-30% large irregular lymphoid cells with lobulated nuclei, consistent with Sezary cells. Results of immunofluorescent staining of cell surface markers on the patient's mononuclear cells (MNC) are listed in Table I. HIV is a patient with acquired immunodeficiency and hyper-IgM as described by Cruchaud et al. (19) . The serum Ig profile consisted of absent IgG and IgA, with an IgM of 1,280 mg%.
Cell Separation and Culture Conditions. 50 ml of heparinized venous blood were obtained from normal laboratory volunteers as well as the patients described above, diluted 1:3 with sterile phosphate-buffered saline (PBS), layered on a FicolI-Hypaque density gradient (Pharmacia Fine Chemicals, Piscataway, NJ), and centrifuged for 30 min at 500 g. The interface cells (MNC) were washed three times in PBS before use. Tonsillar MNC were obtained from routine tonsillectomy specimens, as previously described (14) . T and B cell separation was achieved by a rosetting technique using neuraminidasetreated sheep red blood cells (SRBC) and FicoU-Hypaque density gradient centrifugation (14) .
All cells were cultured in RPMI 1640 (M. A. Bioproducts, Walkersville, MD), 10% fetal calf serum (Reheis Co., Inc., Phoenix, AZ), 1% penicillin, streptomycin (Gibco Laboratories, Grand Island, NY), and 2 mM glutamine (Gibco Laboratories), hereafter designated as complete culture medium (CM). In certain experiments, pokeweed mitogen (PWM) (1:100 dilution; Gibco Laboratories) was added.
Isolation ofslgM ÷ Tonsillar B Cells. Tonsiilar MNC were separated into T and non-T fractions as described above. Interface cells were subjected to a second rosetting to remove contaminating T cells (resultant populations <0.5% OKT3+). Non-T cells were washed three times in PBS and diluted in 5 mi of CM at a concentration of 4 x 106/ml. Ox RBC (ORBC) were coated with an F(ab')2 affinity-purified rabbit anti-human IgG or IgA, using a chromium chloride technique (20) . One ml of a 5% solution of the coated ORBC was added to the tonsilar non-T cells, centrifuged at 200 g for 5 min, and incubated for 20 min at 4°C. The pellet was resuspended in CM, layered on a Ficoli-Hypaque gradient, and centrifuged at 500 g for 30 min at 4°C. The interface cells were sIgM ÷ with rare contaminating sIgG + and sIgA ÷ cells. Immunofluorescent staining of these interface cells with previously described fluorescein-conjugated, affinity-purified F(ab')2 reagents revealed the following: sIgM, 99%; sIgG, 0.3%; and sIgA, 0.01%.
Isolation of Tac ÷ and Tac-cells. The monoclonal antibody Tac (anti-TCGF [T cell growth factor] receptor) was kindly provided by Dr. Thomas Waldmann. To isolate the Tac + cells from patient Rac (30% of peripheral blood lymphocytes [PBL]), an indirect rosetting technique was performed using F(ab')~ affinity-purified goat anti-mouse Igcoated ORBC (14) . Resting T cells from normal controls were uniformly Tac-and, therefore, no isolation was performed on these populations. 40 million TRac cells were incubated with Tac antibody (1:40,000 dilution of original ascites in CM) for 30 rain at 22°C. Cells were washed three times in CM and resuspended in 0.5 ml CM. 0.5 ml of a 2% Ig-coated ORBC solution was added and the mixture was kept on ice for 5 rain. The cells were then spun at 200 g for 5 min at 4°C and further incubated on ice for 30 min. lmmunofluorescence. Standard direct and indirect immunofluorescence was performed as previously described (21) . A cytofluorograph (30-H; Ortho Diagnostic Systems, Inc., Westwood, MA) was used for all fluorescence analysis. OKT3, OKT4, OKT8, and OKM 1 were obtained from Ortho Diagnostic, Raritan, NJ.
Plaque Assay. A reverse hemolytic assay using protein A-coated SRBC was performed as previously described (22) . Affinity-purified rabbit anti-human IgG, IgA, and IgM were obtained from Cappel Laboratories, Cochranville, PA and used at a 1:100 dilution as developing antisera. All cultures were assayed on day 6 unless otherwise indicated. In some experiments, T cells were irradiated (1,500 rad) using a cesium source (Isomedix, Inc., Whippany, N J), before addition to culture.
Results

Characteristics of MNC, T Cells and B CeUs from Patient Rac.
The peripheral blood of this patient contained a malignant clone of T cells that accounted for approximately one-third of the MNC. This was especially evident from the blastoid appearance of these cells and the presence of the Tac antigen on their membrane (Table I) . This picture was similar to that often observed in the type of Sezary cell disease with primary cutaneous manifestations of mycosis fungoides. The Tac positivity permitted isolation of these cells from the peripheral blood. Table I summarizes the results of cell surface staining using various monoclonal antibodies and F(ab')2 affinity-purified rabbit anti-human IgG, IgA, IgM, and IgD. Other than the Tac positivity noted above, results were unremarkable.
Ig analysis of the serum of this patient showed a selective depletion of IgM. Experiments were therefore initiated to determine where the defect in IgM production existed. As seen in Table II (one representative experiment in a series of four), no IgM plaque-forming cells (PFC) were noted when MNC-Rac were cultured in the presence of PWM, whereas IgG and IgA PFC, although consistently lower than the normal control, were present. Co-culture of non-T * One million MNC were cultured with or without PWM or 1 x 10 8 non-T cells were co-cultured with or without allogeneic T cells (I x 10 6) in the presence of PWM. A reverse hemolytic plaque assay was performed on day 6, using class-specific developing antisera.
cells from patient Rac with either autologous or ailogeneic control T cells and PWM yielded similar results, with no IgM PFC but good IgG and IgA responses. The addition of Epstein-Barr virus (EBV) to Rac non-T cells however, did result in the production of some IgM PFC, indicating that the cellular machinery necessary for IgM production and secretion was still present in some cells (data not shown). Experiments were performed to determine whether the T cells from Rac (Trac) were playing a role in the diminished IgM production. Co-culture of control non-T cells with Trac and PWM resulted in a marked absence of IgM PFC (Table  II) , whereas IgA production was unchanged and IgG was only slightly decreased, or unchanged, when compared with control autologous T cells. To determine whether this finding was due to IgM class-specific suppression, two assay systems were used. In the firsL 1 x 106 allogenic MNC and PWM were cultured with 1 X 106 Trac or normal allogeneic T cells. No suppression was noted of any Ig class, either with irradiated or unirradiated Trac or two allogeneic control T cell populations (Table III) . In the second system, irradiated or unirradiated T~ac or control T cells were added to three different iymphoblastoid B cells lines, SeD (IgM, r), 8866P (IgG, K), and 32al (IgA, ~,) and tested for suppression of Ig secretion. 1 × 105 T~ac or control T cells were added to 1 × 10 4 or 1 X 10 5 lymphoblastoid cells, and class-specific Ig secretion was measured at 12, 24, 48, 72, and 96 h. No suppression was seen with Tr~c or control T cells when added to either 8866P or 32A1 (data not shown). Suppression (30-50%) was noted, however, when T cells were co-cultured with SeD, but this response was not specific for T~c. In fact, T=c exhibited the least suppression of the three T cell populations used, at any time tested (data not shown). Thus, since the mechanism of reduced IgM secretion does not appear to be mediated through class-specific suppression, experiments were performed to determine whether Trac was inducing a class switch.
Ability of Trac to Induce a Class Switch from IgM to IgG and IgA.
A model for the assay of T cell regulation of Ig class switching was established as follows. sIgM + tonsillar B cells were used (see Materials and Methods). These were depleted of significant sIgG and sIgA by a direct rosetting technique. IgG and IgA produced after stimulation with T cells was considered evidence suggestive of a class switch, since cells definitively committed to other isotypes were already depleted.
One million #+ tonsillar B cells were co-cultured with 1 × 106 T~ac or one of two different ailogeneic T cell controls and PWM. In three separate experiments (Table IV) , the addition of allogeneic T cells to the tt + tonsillar B cells resulted in the production of increased IgM PFC (range, 5,620-9,870). In addition, IgG and IgA production was also noted (range, 1,760-7,690 and 880-6,400, respectively), although generally lower than that seen with unfractionated B cells (Table  IV legend and data not shown). However, addition of T~ac cells to the tt + tonsillar B cells resulted in little or no IgM PFC (range, 0-220) but induction of IgG and IgA PFC (range, 650-1,000 and 220-2,000, respectively) was still noted. The number of IgG and IgA PFC never achieved the levels seen with normal control T cells but they were always significantly higher than the number of IgM PFC.
Evidence that the Tac + Trac Cells Are Important in the Switching Process. Trac cells were depleted of the 30% Tac + cells by indirect rosetting technique (see Materials and Methods). The resulting Tac-population was no longer capable of inducing an Ig class switch (Table V; Unfractionated Trac cells gave rise to higher numbers of IgG and IgA PFC, suggesting the necessity for additional helper T cells in the differentiation process. The addition of Tac antibody to the cultures (1:40,000 dilution at the concentration used for rosetting) (Table V) or a range of concentrations (1:10,000 to 1:400,000) (data not shown) had no effect on B cell differentiation (19, 23, 24) . Previous attempts (25) (26) to induce IgG and IgA secretion in cells from these patients in vitro have been unsuccessful using various B cell mitogens and allogeneic T cells. Although certain groups (26) this syndrome represents an intrinsic B cell defect, the possibility remains that, in certain patients, there is a defect in switch signals from T cells. To address this possibility, 1 × 106 T~ac or other allogeneic T cells were added to either 1 x 10 ~ MNC or non-T cells from patient HIV (Table VI) , with immunodeficiency and hyper-IgM. As seen in IgG PFC were noted. Similar data were obtained using non-T cells from this patient (Table VI) . T~,c or allogeneic T cells alone in the presence of PWM yielded no PFC response in numerous experiments (Table VI, legend) . Discussion We have demonstrated the existence of a T cell (T~ac) derived from a patient with a mycosis fungoides/Sezary's syndrome, which is capable of inducing an Ig class switch from IgM to IgG and IgA. The evidence for this comes from two different assay systems. Negatively selected #+ tonsillar B cells were used as a model for Ig switching. In the absence of T cells and mitogen, IgG and IgA PFC are not demonstrable (Table IV) . However, when Tr, c cells were added, IgG and IgA PFC were noted, with little or no IgM secretion. Since our data show that IgM production was not actively suppressed by Tr,~ (Table III) , these cells appear to be inducing a nonspecific Ig class switch. This does not address the issue that sIgM + B cells might already be committed to other isotypes at the DNA level. It is still possible that Trac cells might be expanding populations of IgG-and IgAcommitted cells. Indeed, control allogeneic T cells were also capable of inducing IgG and IgA PFC in this system, although, in contrast to T .... significant IgM PFC were also noted (Table IV) . Therefore, on the basis of the above data, either switch T cells are present in small numbers in the normal T cell population, with effects amplified by the large numbers of other T cells secreting various B cell growth and differentiation factors, or the #+ tonsillar B cell assay only depicts the expansion of isotype-committed sIgM-bearing cells.
This same problem has plagued the other studies (15-17) that described switch T cells or factors and where mitogen-stimulated heterogeneous B cell populations were used. To resolve this issue, a source of B cells without any evidence of Ig gene rearrangement must be used as the target population. To this end we have obtained cells from a patient with immunodeficiency and hyper-IgM. As described by Cruchaud et al. (19) , this syndrome is characterized by absent serum IgG and IgA with normal to high levels of serum IgM. In vitro studies (25) (26) performed with B cells from these patients confirmed the lack of IgG and IgA secretion, using various stimuli including normal allogeneic T cells. In addition, the genes encoding for the C, region have been found to be in the germline configuration (S. P. Kwan and F. Rosen, personal communication; in various patients including HIV). Thus B cells from these patients appear to meet the criteria for a model of T cell influence in the regulation of Ig class switching, and should help resolve whether Trac effects a class switch. The data in Table VI suggest that this indeed is the case. Co-culture of normal allogeneic T cells and PWM, or PWM alone, with peripheral blood MNC or B cells derived from a patient with immunodeficiency and hyper-IgM, resulted only in an IgM PFC response (Table VI) . These data are consistent with other in vitro studies in these patients (25) (26) . When T~,c cells and PWM are co-cultured with these same B cells, however, IgG PFC are noted, with a concomitant decrease in IgM secretion. These findings are not confined to the one patient (HIV) described here, as we have now screened several other patients with this disorder who are capable of secreting IgG and/or IgA in the presence of T~ac cells (Mayer, Kwan, Thompson, Chiorazzi, Rosen, and Kunkel, manuscript in preparation). This suggests that there may be a defect, at least with some patients with this syndrome, in "switch" T cells. The fact that normal T cells are unable to correct this defect, as shown here and as previously documented (26) , might reflect quantitative differences in switch signals elaborated by normal and Tr~¢ cells. Alternatively, it may reflect the lack of an appropriate activation stimulus in the normal T cell population. Tra~ cells appear to be a malignant expansion of in vivo activated switch T cells, as evidenced by the finding that the Tac ÷ Tr~c cells appear to be responsible for the switch-inducing activity (Table V) and by the Tac + malignant cells on the skin biopsy of patient Rac (data not shown).
The activation signal for the switch T cells is unknown but it might relate to some T-dependent antigens known to enhance non-u Ig responses (7-9). PWM does not appear to provide an optimal stimulus for Ig class switching (27-28), although some low-level switching might still occur. This might explain, in part, why normal T cells in the presence of PWM are unable to induce an Ig class switch in B cells from patients with the hyper-IgM syndrome. It might also explain why T cells from patients with this syndrome function normally in B cell differentiation assays, (26) . Although these patients may have a defect in switch T cells, other T cell functions, such as secretion of B cell growth and differentiation factors, are presumably intact. Thus, co-culture of hyper-IgM T cells with IgG-and IgA-committed B cells would result in IgG and IgA secretion, respectively.
The mechanism by which T,.,c cells induce an Ig class switch is unclear. It is possible that the T cell secretes a recombinase or recombinase activator (29) .
However, supernatants from lectin-stimulated T~ac cells or from a Tac +, IL-2-dependent T~c cloned cell line (active in inducing an Ig class switch) have failed to induce switching. These supernatants are also deficient in nonspecific BCDF or BCGF, which may account for the relatively low levels of IgG and IgA PFC seen in our experiments. Thus, the presence of Trac cells appears to be necessary for actual switching to occur, although we cannot rule out the possibility that switch factors are present in concentrations too low to have any effect in our assay systems. The presence of both IgG and IgA PFC suggests that the T=c signal might mediate an early, nonspecific event, shutting off # or 6 secretion, and allowing for other switch signals to act more specifically. This is supported by the finding that sIgD is rapidly lost from the B cell surface within 12 h of coculture with T~c (Mayer, Kwan et al., manuscript in preparation).
The accumulated evidence suggests that there is a T cell capable of regulating Ig class switching. Whether this malignant clone of T cells is a part of the normal physiologic process (part of a series of switch T cells) is currently being investigated. The finding of a reversal of a switching defect in patients with immunodeficiency and hyper-IgM suggests that this may be so.
Summary
Evidence is presented for the existence of a "switch" T cell derived from a patient with mycosis fungoides/Sezary's syndrome. The serum immunoglobulin profile in this patient revealed high IgG and IgA but no detectable IgM. Peripheral blood mononuclear cells from this patient secreted only IgG and IgA in the presence of pokeweed mitogen. T cells (T~ac) co-cultured with normal allogeneic non-T cells and pokeweed mitogen resulted in only IgG and IgA PFC, with little or no IgM secretion. There was no evidence of active suppression of IgM. Rather, these T cells appeared to induce an Ig class switch from IgM to IgG and IgA, when co-cultured with #+ tonsillar B cells. Further evidence was obtained using mononuclear cells derived from a patient with immunodeficiency and hyper-IgM, a syndrome characterized by a lack of IgG and IgA secretion. The addition of Tr,c cells to either peripheral blood mononuclear cells or non-T cells from a patient with hyper-IgM syndrome resulted in new secretion of IgG, with a concomitant decrease in IgM secretion, whereas control T cells were not effective in inducing secretion of any isotype other than IgM. Isolated Tac ÷ T cells from Tr,c appear to be responsible for this effect.
